| Patents for C07D 237 - Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings (8,468) |
|---|
| 04/01/2003 | CA2288439C Biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin |
| 03/27/2003 | WO2003024938A1 Phthalazinones and the use thereof in order to combat undesirable microorganisms |
| 03/27/2003 | WO2003024441A1 Novel use of tricyclic compound |
| 03/26/2003 | EP1294724A1 Pyrrolo[2,3-d]pyrimidine compounds as immunosuppressive agents |
| 03/26/2003 | EP1294380A1 A method for treating septic shock |
| 03/26/2003 | CN1406228A 4-oxo-1,4-dihydro-3-cinnolinecarboxamides as antiviral agents |
| 03/25/2003 | US6538135 Amination of 4,5-dichloro-1-phenylpyridazin-6-one with aqueous ammonia in presence of phenolic catalyst |
| 03/25/2003 | US6537991 A method of treating a peripheral neuropathic pain in a warm-blooded animal requiring such treatment which comprises administering to said animal a therapeutically effective amount of an EP1-type prostaglandin receptor antagonist |
| 03/20/2003 | US20030055248 Il-8 receptor antagonists |
| 03/20/2003 | US20030055093 For therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction |
| 03/20/2003 | US20030054298 Color photography; bleaching, fixing, development |
| 03/18/2003 | US6534492 Uracil substituted phenyl sulfamoyl carboxamides |
| 03/13/2003 | WO2002078625A3 Therapeutic combinations for cardiovascular and inflammatory indications |
| 03/12/2003 | EP0672031B1 Catechol diethers as selective pde iv inhibitors |
| 03/11/2003 | US6531473 Method of treatment using arylalkylpyridazinones |
| 03/11/2003 | US6531241 Anions of equal number to cations to maintain charge neutrality, are disclosed. These spacer groups may be organic or inorganic in origin and may vary in length. The spacer groups may be saturated, containing single bonds, or may have |
| 03/06/2003 | WO2003018563A1 Anti-inflammatory and protein kinase inhibitor composition and method of use |
| 03/06/2003 | WO2003017765A1 Treatment for cystic fibrosis |
| 03/05/2003 | EP1286968A2 Substituted iminoazines |
| 03/04/2003 | US6528649 Imidazoloisoquinolines |
| 03/04/2003 | US6528543 Glucokinase activating for treating type II diabetes; acylurea compound, phenylacetyl-substituted; 1-(2-(3-chloro-phenyl)-3cyclopentyl-propionyl)-3-methyl-urea |
| 02/27/2003 | WO2003016286A1 3-phenoxy-4-pyridazinol derivative and herbicide composition containing the same |
| 02/27/2003 | WO2003015785A1 2h-phthalazin-1-ones and methods for use thereof |
| 02/27/2003 | WO2003015774A1 Compounds effecting glucokinase |
| 02/27/2003 | US20030040516 Pyrazinone inhibitors of fatty acid binding protein and method |
| 02/27/2003 | CA2456985A1 2h-phthalazin-1-ones and methods for use thereof |
| 02/26/2003 | EP0971901B1 Phthalazinones |
| 02/26/2003 | CN1399573A Use of phthalazine derivatives |
| 02/25/2003 | US6525072 Prevention and treatment of cellular disorders such as cancer |
| 02/25/2003 | US6525053 2-Benzyl-5-(4-methylsulfonylphenyl)-6-(4-fluorophenyl)-3(2H) -pyridazinone; cyclooxygenase (COX) inhibitors pain, fever, inflammation, rheumatoid arthritis, osteoarthritis; minimizes GI and renal side-effects |
| 02/20/2003 | WO2003014090A1 Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 02/20/2003 | WO2003013484A2 N-monoacylated derivatives of o-phenylenediamines, their six membered heterocyclic analogues and their use as pharmaceutical agents |
| 02/20/2003 | WO2002096516A8 Use of compositions comprising cyclooxygenase-2 selective inhibitors in combination with radiation for inhibition or prevention of cardiovascular disease |
| 02/20/2003 | WO2002068399B1 Aryl carbamate derivatives, preparation and use thereof |
| 02/20/2003 | WO2002024635A3 Aminoalcohol derivatives |
| 02/20/2003 | CA2455759A1 Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 02/19/2003 | CN1398258A 4-hydroxycinnoline-3-carboxyamides as antiviral agents |
| 02/19/2003 | CN1398252A Dehydroamino acids compounds |
| 02/13/2003 | US20030033089 Substituted quinazolines and analogs and the use thereof |
| 02/11/2003 | US6518310 Non-peptidic; inhibits trypsin-like protease, thrombin and embolus formation; anticoagulant |
| 02/06/2003 | WO2003010153A1 N-alkyl-n-phenylhydroxylamine compounds containing metal chelating groups, their preparation and their therapeutic uses |
| 02/06/2003 | WO2003010150A1 Polymorph salt of a pyridazinone derivative for the treatment of arrythmia |
| 02/06/2003 | CA2454774A1 Polymorph salt of a pyridazinone derivative for the treatment of arrythmia |
| 02/05/2003 | EP1280780A2 Asymmetric synthesis of piperazic acid and derivatives thereof |
| 02/05/2003 | CN1100748C Inhibition of matrix metalloproteases by 2-substituted-4-(4-substituted phenyl)-4-oxobutyric acids |
| 02/04/2003 | US6515124 Dehydroamino acids |
| 02/04/2003 | US6514983 Inhibitors of the nucleic enzyme poly(adenosine 5'-diphospho-ribose)polymerase |
| 02/04/2003 | US6514971 Cinnoline derivatives and use as medicine |
| 01/30/2003 | US20030023087 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use |
| 01/29/2003 | EP1278723A2 P-(sulfonyl)-aryl and -heteroaryl amines |
| 01/28/2003 | US6512111 A method for preparing compounds of formula (I) ) wherein cyclization is carried out in a basic medium and in the presence of a phosphonic acid derivative and the use of said method as an intermediate step for preparing a compound |
| 01/28/2003 | US6511987 Heterocyclic derivatives that bind to the benzodiazepine site of GABAA receptors for treatment of central nervous system disorders |
| 01/23/2003 | WO2003006454A2 Heterocyclic carboxamides and their use as fungicides |
| 01/23/2003 | WO2003006423A1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 01/23/2003 | WO2003006023A1 Pyrazinone inhibitors of fatty acid binding protein and method |
| 01/23/2003 | CA2453503A1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 01/22/2003 | EP1277729A1 Ppar (gamma) modulators |
| 01/22/2003 | CN1099417C New polycyclic 2,3-phthalazine derivatives and their use |
| 01/16/2003 | WO2003004474A1 Pesticidally active aminoacetonitriles |
| 01/16/2003 | WO2003004035A1 New use of a pyridazinone derivative |
| 01/16/2003 | US20030013713 Compounds as PDE IV and TNF-inhibitors |
| 01/16/2003 | CA2450821A1 New use of a pyridazinone derivative |
| 01/15/2003 | EP1275301A1 Trisubstituted heterocyclic compounds and their use as fungicides |
| 01/15/2003 | EP1274689A2 Sulfur containing dihydrophthalazine antagonists of excitatory amino acid receptors |
| 01/15/2003 | EP1274428A2 Il-8 receptor antagonists |
| 01/15/2003 | CN1390547A Therapy for tissue damage by local ischemia |
| 01/09/2003 | WO2003002541A1 Pyridazinone |
| 01/09/2003 | US20030009033 Substituted condensation products of N-benzyl-3-indenylacent amides with heterocyclic aldehydes for neoplasia |
| 01/09/2003 | US20030008915 Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical agents |
| 01/09/2003 | US20030008871 Administering sulfonyl pyridazinone compounds for therapy and prophylaxis of tissue damage resulting from ischemia |
| 01/09/2003 | CA2451755A1 Pyridazinone |
| 01/08/2003 | EP1272476A1 2-phenyl-2h-pyridazine-3-ones |
| 01/08/2003 | EP1272475A1 2-phenyl-2h-pyridazine-3-ones |
| 01/08/2003 | EP1272474A1 Substituted 5-methyldihydropyridazinones and their use in the prophylaxis and/or treatment of anemias |
| 01/08/2003 | EP1272456A1 Hydrazide and alkoxyamide angiogenesis inhibitors |
| 01/08/2003 | CN1390217A Bicyclic and tricyclic heteroaromatic compounds |
| 01/02/2003 | US20030004139 Antidiabetic agents |
| 01/02/2003 | EP1268443A1 2-hydroxy-mutilin carbamate derivatives for antibacterial use |
| 12/31/2002 | US6500951 Process for preparing pyridazin-3-on derivatives |
| 12/31/2002 | US6500847 Inhibition of matrix metalloproteases by substitued biaryl oxobutyric acids |
| 12/27/2002 | WO2002044157A3 Parb inhibitors |
| 12/26/2002 | US20020198208 Medicinal preparation and process for manufacturing thereof |
| 12/26/2002 | US20020198207 Novel Hexanoic acid derivatives |
| 12/24/2002 | US6498275 Use of compounds for the elevation of pyruvate dehydrogenase activity |
| 12/24/2002 | US6498160 For therapy of emphysema, chronic bronchitis, asthma and allergic rhinitis |
| 12/24/2002 | US6498159 Such as 4-((3-chloro-4-methoxybenzyl)amino)-1-((4-hydroxy-4 -hydroxymethyl)piperidino)-6-phthalazine carbonitrile |
| 12/24/2002 | CA2150812C Catechol diethers as selective pde iv inhibitors |
| 12/19/2002 | WO2002085906A3 Phthalazinones derivatives useful as pde4/7 inhibitors |
| 12/19/2002 | WO2002055501A3 N-pyridyl carboxamide derivatives and pharmaceutical compositions containing them |
| 12/19/2002 | US20020193596 Inhibitors of protein isoprenyl transferases |
| 12/18/2002 | EP1266651A2 UV absorbing and photostabilizing agents and compositions and external preparation for skin |
| 12/18/2002 | EP1265873A2 4-oxo-1,4-dihydro-3-cinnolinecarboxamides as antiviral agents |
| 12/18/2002 | EP1265872A1 4-hydroxycinnoline-3-carboxyamides as antiviral agents |
| 12/18/2002 | EP1265871A1 Pyridazinyl phenyl hydrazones useful against congestive heart failure |
| 12/12/2002 | WO2002098849A2 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer’s disease and similar diseases |
| 12/12/2002 | CA2448834A1 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer's disease and similar diseases |
| 12/11/2002 | EP1264820A1 Novel amide compounds |
| 12/11/2002 | EP1263723A1 Ningalin b analogs employable for reversing multidrug resistance |
| 12/11/2002 | EP0752813B1 Inhibitors of metazoan parasite proteases |
| 12/11/2002 | EP0624155B2 Carbamates and plant-protecting agents containing them |